Last update:
Medications news
GLP-1 drugs effective for weight loss, but more independent studies needed
Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform ...
3 hours ago
0
0
Antibiotics linked to lower risk of complications after obstetric tear
Giving antibiotics to women within 24 hours of an obstetric tear during childbirth is associated with a reduced risk of larger/clinically relevant wound complications, find the results of a clinical trial from Denmark published ...
6 hours ago
0
0
US aims to quicken approvals for cheaper versions of complex drugs
The US Food and Drug Administration said Wednesday it would ease the approvals process for developing replicas of biologic drugs used to treat conditions including autoimmune diseases, cancer and diabetes.
8 hours ago
0
0
New imaging technique maps drug movement through skin in minutes
By combining mass spectrometry imaging with an automated analysis tool, researchers from Hebrew University have developed a technique that maps medication distribution across skin layers without dyes or labels. Tested on ...
10 hours ago
0
0
Q&A: New drug being reviewed by the FDA to treat Parkinson's disease
The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements.
15 hours ago
0
5
Home treatment with IV antibiotics could relieve NHS pressure
Treating patients at home with IV antibiotics, rather than in a clinical setting, could halve costs to the NHS and relieve pressure on hospital beds—according to a University of East Anglia study.
15 hours ago
0
0
Drugs approved for treating pain may also reduce bone cancer growth
Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and spinal cord)—are known to infiltrate and grow within malignant bone tumors called osteosarcomas, ...
Oct 28, 2025
0
28
FDA approves Tezspire for chronic rhinosinusitis with nasal polyps
The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients ...
Oct 28, 2025
0
0
Whole tablets may be safer than crushed ones for patients with poststroke swallowing disorders
For decades, stroke patients with swallowing difficulties have routinely received crushed tablets to reduce the risk of aspiration. New clinical data now challenge this practice. A study using endoscopic swallowing diagnostics ...
Oct 28, 2025
0
0
Efforts to promote safer opioid prescribing in Canada appear to be having an effect
Efforts to promote safer opioid prescribing in Canada appear to be having an effect, as new research in the Canadian Medical Association Journal shows a decrease in opioid dispensing between 2018 and 2022.
Oct 27, 2025
0
0
Experimental inhibitor reduces cell death in models of life-threatening skin reactions
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous adverse reactions such as Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
Oct 24, 2025
0
0
New drug tested in mice could fill treatment void for most severe heart attack patients
A new drug being trialed in heart attack patients could reprogram the immune system to prevent inflammation and heart damage following severe heart attacks, and promote repair. This could be a game-changer in treating the ...
Oct 24, 2025
0
1
Parent opioid prescriptions linked to teen and young adult opioid use
If a parent has persistent opioid prescriptions, their adolescent or young adult offspring has more than double the risk of persistent opioid use, according to a new study published in PLOS Medicine by Anna Marcuzzi of the ...
Oct 23, 2025
0
6
Psilocybin + mindfulness show promise for health care worker depression
Front-line health care workers struggling with depression after the COVID-19 pandemic experienced significant relief from a treatment combining psilocybin group therapy with mindfulness training, according to a new study ...
Oct 23, 2025
0
20
Experimental targeted therapy shows promise for histiocytosis, a rare blood cancer
The first time Joey Carlsen Martinez came to Memorial Sloan Kettering Cancer Center (MSK), he was in terrible shape. He had a rare blood cancer called Erdheim-Chester disease, and his symptoms included crushing fatigue, severe ...
Oct 23, 2025
0
0
Novel drug combinations pave the way for personalized leukemia therapies
Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a review on BH3 mimetics—a new class of drugs that are reshaping the treatment landscape for acute myeloid ...
Oct 23, 2025
0
0
New drug study shows improved survival for early breast cancer
Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer.
Oct 23, 2025
0
0
Antidepressants show promise for alleviating jaw pain
Certain antidepressants can help alleviate chronic jaw pain caused by temporomandibular disorders (TMDs), according to a research review by a team of researchers with expertise in dentistry and pharmacy published in the Journal ...
Oct 23, 2025
0
0
Amid the noise about Tylenol, there's a real risk—an overdose
While news feeds and social media are abuzz with unproven claims about links between acetaminophen and autism in children, there are well-established concerns about the harmful effects of an overdose of the over-the-counter ...
Oct 23, 2025
0
0
Cancer drug quality in Africa is a worry, four-country study finds
The number of people receiving treatment for cancer has risen dramatically in the last decade in many African countries. For example, 10 years ago in Ethiopia and Kenya, cancer care was available to only a few thousand patients ...
Oct 22, 2025
0
0
No benefit from ketamine for patients hospitalized with depression, clinical trial reports
Findings from a randomized and blinded clinical trial investigating repeated ketamine infusions for treating depression have revealed no extra benefit from ketamine when added to standard care for people admitted to hospital ...
Oct 22, 2025
0
0
Stopping long-term opioid treatment unlikely to increase suicide risk, major study finds
People on long-term opioid treatment can be reassured that stopping these medicines is not likely to increase their risk of suicide or fatal overdose, thanks to a major new study from the National Drug and Alcohol Research ...
Oct 22, 2025
0
0
Antidepressants vary widely in their physical side effects, highlighting the need for personalized prescribing
Antidepressants can differ widely in how they physically affect the body, including around a 4 kg difference in weight change between certain drugs (approximately 2.5 kg weight loss from agomelatine and 2 kg weight gain from ...
Oct 21, 2025
0
0
